OpportunityTitle: Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-Rare Awardees (Admin Supp)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; This funding opportunity is intended to provide support through an administrative supplement to existing Rare Diseases Clinical Research Network (RDCRN) awardees whose projects encompass the implementation of clinical trials.
Description: This funding opportunity is intended to provide support through an administrative supplement to existing Rare Diseases Clinical Research Network (RDCRN) awardees whose projects encompass the implementation of clinical trials. Through this supplement, NCATS intends to provide support for phase 1 and/or 2 clinical trial sites that will test the potential use of an existing molecule for the treatment of a rare disease as part of a multi-site international E-Rare-3 trial.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;